Search

everythinglearnresearchcommunity

for

Search:↓

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Microneedling helps with hair loss, especially with 5% minoxidil, but more high-quality research is needed.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.